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Abstract 
Objective: The present research was aimed to understand the molecular docking efficiency of a plant-derived compound cleistanthin-A and a 
common ingredient in tobacco consumption nicotine with nicotinic acetylcholine receptor (nAChR). 
Methods: The 3-D structure of nAChR was retrieved from the protein data bank (ID 5AFH). Ligand was obtained from the PUBCHEM. The in silico 
protocol comprised of three steps: high-throughput virtual screening (HTVS), standard precision (SP) and extra precision (XP). The screened 
molecules were ranked accordingly using glide score. Schrödinger tool was used to perform the docking analysis.  
Results: The binding efficiency of the nicotine and cleistanthin-A was found to be docked at the cys-cys loop of the receptor. Based upon the glide 
score and glide energy it can be reported that, nicotine binding can be inhibited by the binding of cleistanthin-A to the nAChR.  
Conclusion: The docking efficiency of cleistanthin-A was good compared to nicotine towards nAChR. Hence, cleistanthin–A was derived as a better 
choice as an alternative for nicotine in smoke therapy.  
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India is extremely famous for its mega biodiversity resources [1]. 
Medical uses of various herbal formulations were highlighted in the 
Ayurvedic literature sidhasarasamhitawritten during the 8th century 
[2]. The economic importance of Indian plant species are increasing 
globally because of the medicinal properties of their active chemical 
constituents [3]. All parts of the plant like leaves, roots, stem, 
flowers, seeds and fruits were used in active drug formulations [4]. 
Hence, most of our researchers were focused on plants and plant-
derived constituents to address various kinds of medical issues.  
The habit of cigarette smoking is very fatal throughout the world. In 
spite of so many anti-smoking therapies available, the smoking habit 
still continues among all the groups of people. Nicotine triggers 
dopamine secretion in the brain and thus the habit continues and 
smoking becomes a chronic disorder. Because of routine smoking, 
nicotine enters into the human body and causes deleterious effects 
such as lung cancer and opportunistic disorders like tuberculosis. If 
an alternative molecule is discovered, this can reverse or block the 
effect of nicotine [5]. The unique binding orientation of two different 
molecules with each other can be detected using molecular docking 
analysis [6]. 
Nicotine (fig. 1) binds to the same neuroreceptor to which 
acetylcholine binds. There are five domains namely α1-10, β1-4, γ, δ, 
ε selected from a group of seventeen homologous polypeptide 
sequences which forms the transmembrane part of the receptor [7]. 
There are four transmembrane segments and external N-terminal 
forms the cys-cys loop on each of the receptors and have a molecular 
weight of 290 kDa [8, 9]. The function of nAChR is hampered when 
nicotine binds to it. 
The ligand binding domain is 20 A˚ long and 40 A˚ in diameter, 
which spreads from membrane surface on the opposite side of the 




Fig. 1: Structure of nicotine 
 
Cleistanthin-A (fig. 2) is the active constituent of the poisonous 
plant, Cleistanthus collinus (Roxb.) Benth. ex Hook. f. Cleistanthin-A 
compound was first isolated and named as cleistanthin [11]. 
Another related compound was later identified from the same plant 
species. Hence, cleistanthin was renamed as cleistanthin-A, lately 
identified compound was named as cleistanthin-B [12]. Cleistanthin-
A, though belongs to the poisonous plant, the recent publications 
reported many of its therapeutic properties. The anti-hypersensitive 
effect and diuretic effect are few examples of this category [13, 14]. 
The anticancer potentials of cleistanthin-A were also reported by 
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many researchers [15-17]. The present study was aimed to analyze 
the docking properties of cleistanthin-A against nAChR. 
 
 
Fig. 2: Structure of cleistanthin–A 
 
MATERIALS AND METHODS 
Receptor 
The 3-D structure of nAChR (fig. 3) with 2.4 A˚ resolution was 
retrieved from the protein data bank (ID 5AFH). 
 
 
Fig. 3: Structure of nAChR 
 
Ligand preparation 
Ligand for the present study was obtained from the PUBCHEM. The 
compound’s structural coordinates were retrieved in the mol 
format. Structural coordinates were converted from 2-D to 3-D 
formats and were energetically minimized using the optimized 
potentials for liquid simulations (OPLS) force field. The chiral centre 
of the ligand was used to retain the original state and this also helps 
in the prevention of stereoisomer generation.  
Structure-based virtual screening 
Virtual screening is one of the potential screening methodologies 
used to identify the possibilities of the ligand-receptor binding 
efficiency. The in silico protocol comprised of three steps: HTVS, SP 
and XP. The screened molecules were ranked accordingly by using 
glide scores [18]. 
Glide docking 
For ligand docking, the glide version 6.1 protocol was used in the 
present study. The active site of the prepared protein was defined 
using default parameters of receptor-grid generation present in the 
glide module. Once the receptor grid was generated, the ligands 
were docked using the XP docking protocol [19]. The receptor-
ligand complex interaction scores, i.e., glide scores, were calculated 
based on the following equation:  
Glide score = 0.065× vdW+0.130× Coul+Lipo+Hbond+Metal+BuryP+ 
RotB+Site where vdW signifies van der Waals energy, Coul represents 
Coulomb energy, Lipo denotes lipophilic term derived from hydrophobic 
grid potential, Hbond means hydrogen-bonding term, Metal means 
metal-binding term, BuryP implies penalty for buried polar groups, RotB 
infers penalty for freezing rotatable bonds, and Site means polar 
interactions in the active site. 
RESULTS 
The molecular docking for nicotine and cleistanthin-A on nAChR was 
performed using the Schrödinger tool (fig. 4 and 5). 
 
 
Fig. 4: Docking interaction of nicotine with nAChR 
 
 
Fig. 5: Docking interaction of cleistanthin-A with nAChR 
 
The in silico screening of the ligand and the receptor was proved 
useful in drug discovery. This tool gives a higher resolution of the 
target receptors and the docking molecules. The induced fit docking 
predicts the molecule, docking with its receptor. Hence, in this 
present investigation, through schrödinger tool, the binding 
efficiency of the nicotine and cleistanthin-A was found to be docked 
at the cys-cys loop of the receptor. The glide score and the glide 
score energy values were calculated and tabulated (tables 1 and 2). 
 
Table 1: Docking value of nicotine 
Title EntryID Entry name PDB title PDB 
ID 
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Table 2: Docking value of cleistanthin-A 
Title Entry 
ID 
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DISCUSSION 
As the entire bioinformatics was based upon the prediction, there 
was always thirst for tools with high precision. Many tools were 
quite frequently used in the field of biotechnology and 
pharmaceutical industries [20]. The Schrödinger tool was a suitable 
pharmacophore modelling software which helped the researchers to 
create 3-D structure-activity relationships between the receptor and 
ligand structure. It was also a versatile tool for the researcher to 
create and save multi-conformer database for later screening, 
database set-up and multi-pharmacophore screening (info@ 
Schrödinger. com).  
Grid-based ligand docking with energetic commonly called as glide 
[21]. Glide was designed to perform positional, orientation and 
conformational positioning. This also enabled the ligand–receptor to 
be screened through large computational libraries with high speed. 
The calculation of glide score was based upon chem score [22]. 
Glide, placed the ligand at the centre site point of the receptor, if the 
match was accurate otherwise skipped over the point if there was no 
match. Glide energy was modified by van der Waals interaction. The 
minimum energy docked complex was found in the majority of 
similar docking conformations. Finally, the lowest-energy docked 
complex was selected for further study.  
CONCLUSION 
India is the third largest country in tobacco production, and Indians 
are the second largest consumers of tobacco, according to Global 
Adult Tobacco Survey (GATS 2017). It is a herculian task for our 
government to create awareness and control the adverse effects of 
tobacco that includes cancer and tuberculosis. Based upon the 
present study, the binding efficiency of the cleistanthin–A was good 
compared to the binding efficiency of nicotine with nAChR. Hence, 
the phytoconstituent cleistanthin–A could be a considered better 
choice for the pharmaceutical industries to generate an alternative 
for nicotine in smoke therapy. The formulations of cleistanthin-A as 
a drug can largely help in the reduction of the withrawal symptoms 
due to the prolonged addiction of nicotine. 
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